Isotechnika Pharma Inc. Receives Additional Funding From the Government of Canada for NICAM Program
EDMONTON, Alberta, July 17, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") today announced that it has received approval for funding from the National Research Council Industrial Research Assistance Program (NRC-IRAP) for its Non-Immunosuppressive Cyclosporin Analog Molecules ("NICAMs") program.